
In first for EU, anti-skin cancer drug approved
French pharmaceutical giant Sanofi on Friday said the European Medicines Agency had conditionally approved its anti-cancer drug Libtayo, the first drug of its kind to be authorised for use in the EU.
Apr 26, 2019
0
170